(Q73366506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

31 December 2023

author name string

Akira Miyajima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tomohiko Asano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Kaori Seta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Takako Asano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Narihiko Kakoi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Masamichi Hayakawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0090429502025530?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

https://api.elsevier.com/content/article/PII:S0090429502025530?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

31 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1072-1077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

Transforming growth factor-beta: recent progress and new challenges

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Serum transforming growth factor-beta1 in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902553-0

7 January 2021

Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells

14

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients

31 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(02)02553-0

31 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12736050%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference